Posttransplant Cyclophosphamide Allows Allogeneic Stem-Cell Transplantation across Donor Types for Nonmalignant Hematologic Diseases.

Transplantation and Cellular Therapy 2026

View at publisher

Authors: Goonja Shah, Xiaoyan Deng, Baldeep Mona Wirk

DOI: 10.1016/j.jtct.2025.12.203

Cited by: 0

Fields of Study & Subjects

Hematopoietic Stem Cell Transplantation Transplantation: Methods and Outcomes Immunodeficiency and Autoimmune Disorders